Research Article

Contrast-Enhanced Computed Tomography Does Not Provide More Information about Sarcopenia than Unenhanced Computed Tomography in Patients with Pancreatic Cancer

Table 4

Differences in PMD measurements using contrast-enhancement CT.

PMD (mean ± SD)F value value

Unenhanced phase34.311 ± 7.535188.046
Arterial phase37.478 ± 7.118
Portal-venous phase40.689 ± 7.116
Delayed phase42.989 ± 7.745